首页> Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association> Outcomes in patients with chronic kidney disease not on dialysis receiving extended dosing regimens of darbepoetin alfa: long-term results of the EXTEND observational cohort study.

Outcomes in patients with chronic kidney disease not on dialysis receiving extended dosing regimens of darbepoetin alfa: long-term results of the EXTEND observational cohort study.

导出 OA

翻译打印收藏纠错

第一作者： Jan-Christoph,Galle

第一单位： Klinik für Nephrologie und Dialyseverfahren, Klinikum Lüdenscheid, Lüdenscheid, Germany.

作者： Jan-Christoph,Galle ^[1] ; Janet,Addison ^[2] ; Michael G,Suranyi ^[3] ; Kathleen,Claes ^[4] ; Salvatore,Di Giulio ^[5] ; Alain,Guerin ^[6] ; Hans,Herlitz ^[7] ; István,Kiss ^[8] ; Mourad,Farouk ^[9] ; Nick,Manamley ^[10] ; Gerhard,Wirnsberger ^[11] ; Christopher,Winearls ^[12]

作者单位： Klinik für Nephrologie und Dialyseverfahren, Klinikum Lüdenscheid, Lüdenscheid, Germany. ^[1] Amgen Ltd, Cambridge, UK. ^[2] Renal Unit, Liverpool Hospital, Sydney, Australia. ^[3] Department of Nephrology and Renal Transplantation, University Hospitals Gasthuisberg, Leuven, Belgium. ^[4] Department of Nephrology, Dialysis and Transplantation, Ospedale San Camillo-Forlanini, Rome, Italy. ^[5] Clinique du Mont-Louis, Paris, France. ^[6] Department of Molecular and Clinical Medicine/Nephrology, Institute of Medicine, The Sahlgrenska Academy at the University of Gothenburg, Göteborg, Sweden. ^[7] South-Buda Nephrology Centre (Department of Nephrology-Hypertension of St Imre Teaching Hospital and B. Braun Avitum Hungary CPLC 1st Dialysis Centre), Budapest, Hungary. ^[8] Clinical Development, Amgen (Europe) GmbH, Zug, Switzerland. ^[9] Biostatistics, Amgen Ltd, Cambridge, UK. ^[10] Department of Internal Medicine, Medical University of Graz, Graz, Austria. ^[11] Oxford Kidney Unit, Churchill Hospital, Oxford, UK. ^[12]

关键词 anaemia chronic kidney disease darbepoetin alfa erythropoiesis-stimulating agent extended dosing